Zantac Remains Off Of Store Shelves More Than A Year After NDMA Contamination Was Discovered

Little is know for sure as to why ranitidine develops high levels of NDMA, a known carcinogen

Tuesday, March 2, 2021 - Over 15 million Americans were taking Zantac regularly in April 2020, when the US Food and Drug Administration (FDA) banned the drug due to accusations that ranitidine was inherently unstable and deteriorated into a carcinogenic substance. Loyal customers were left without their preferred brand of antacid and were forced to look for alternatives after the FDA recalled all forms of ranitidine and prohibited their sale over the counter and by prescription. The FDA recommended former Zantac users consider protein pump inhibitor (PPI) class antacids to replace Zantac. According to drug watch.com, "FDA recommended alternatives to Zantac (ranitidine) include: Prilosec (omeprazole), Nexium (esomeprazole), Prevacid (lansoprazole), Pepcid (famotidine) and Tagamet (cimetidine)." Also, heartburn sufferers are choosing a quick fix to their indigestion by purchasing fast-acting, over-the-counter Maalox, Mylanta, Rolaids, and Tums. Iherb.com tells readers that baking soda can help neutralize acids that are rising out of the stomach. "Baking soda, or sodium bicarbonate, has a pH level of 7.0, making it a basic substance. Its high pH can neutralize the stomach acid in the esophagus that is causing heartburn," according to IH. Mixing a little baking soda into a glass of warm water and drinking it can temporarily alleviate heartburn."

People with severe, chronic pain caused by gastrointestinal disease (GERD) are getting their prescriptions filled online by Valisure.com. The pharmacists and scientists at Valisure test prescription drugs for purity, freshness, and safety and issue customers a certificate when dispensing medicine. Valisure was the first to test Zantac for contaminates and found levels of carcinogenic NDMA thousands of times greater than the 96 NGS allowed by the FDA. The company immediately notified Sanofi, the maker of Zantac, and the company did the responsible thing and voluntarily pulled their product off the market. More than a year later, Zantac remains off of store shelving. Zantac cancer lawsuits against Sanofi, the makers of Zantac, for failing to warn consumers of the cancer risks of taking the medicine have been filed. Many accuse Zantac of causing stomach, bladder, esophagus, colon, prostate, and breast cancer. Plaintiffs allege Sanofi knew or had a responsibility to know that ranitidine was unstable and could deteriorate under certain conditions.

Zantac became the best-selling anti-heartburn and acid reflux medicine due to lifestyle and diet factors that can cause the condition. Excessive leisure habits, living a sedentary lifestyle, eating meat and sugar-based diet, being overweight, and performing a high-stress job all have a detrimental effect on the digestive system and can cause excess stomach acid production. Of all of these, overeating can be the leading cause of heartburn and acid indigestion because a full stomach can prevent the esophageal sphincter from completely closing which could allow stomach acid to travel up to the esophagus and burn the delicate tissues. It is logical to recommend that the first thing that a person should do when heartburn indigestion pain occurs is to stand up.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
• Zantac 360 Famotidine May Be Saving Covid-19 Patient Lives | 2/4/2022
• Valisure's Ranitidine Testing Method May Not Matter As Sanofi Could Be Held Responsible For Failing To Warn Customers | 2/1/2022
• Their Will Be A Battle Concerning The Way Valisure Tested Zantac Ranitidine For NDMA | 1/27/2022
• Covid Pandemic Requires Remote Depositions For Zantac Cancer Cases In Multidistrict Litigation | 1/26/2022
• Breast Cancer Has Been Specifically Excluded From Federal Zantac Cancer MDL | 1/24/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.